Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Dipstick Control Monitors Urine Tests

By LabMedica International staff writers
Posted on 16 Oct 2011
A point-of-care dipper urine-dipstick control monitors the performance of visual and instrumental readings of urine dipsticks by immersing the dipstick into the control–the same way patient samples are tested.

The liquid control is made from human urine and it simulates patient testing. More...
It is stable at when stored at 2 °C to 8 °C after being opened for 3 months (20 dips) and unopened for 18 months. It is stable at room temperature for one month when opened—this allows for maximum portability.

The Dipper, the Dropper, and the Dropper Plus are all products of Quantimetrix Corp. (Redondo Beach, CA, USA). The urine dipstick-control solution is the same in all three products. However, the packaging configuration, procedure for dipstick testing, and relative stability are different. With the Dipper, a technician actually dips the dipstick into the vial of solution. With the Dropper and Dropper Plus, a technician drops the solution onto the reagent pads.

Values for all dipstick analytes plus microalbumin and creatinine as well as qualitative results for human chorionic gonadotropin (hCG) early pregnancy detection test methods are included. The control is designed for use with most urinalysis reagent strips. It can also be used for confirmatory tests and refractometry.

Quantimetrix develops and manufactures clinical diagnostic products for domestic and international distribution including Lipoprint, a test for measuring LDL subfraction cholesterol. Other products include urinalysis, general chemistry, and specialty chemistry controls. They are liquid, ready to use, with long-term stability. Additional products include electrophoresis systems, diagnostic assays, and OEM.

Related Links:

Quantimetrix Corp.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.